MX9710181A - Moleculas modificadas de avidina y estreptoavidina y uso de las mismas. - Google Patents
Moleculas modificadas de avidina y estreptoavidina y uso de las mismas.Info
- Publication number
- MX9710181A MX9710181A MX9710181A MX9710181A MX9710181A MX 9710181 A MX9710181 A MX 9710181A MX 9710181 A MX9710181 A MX 9710181A MX 9710181 A MX9710181 A MX 9710181A MX 9710181 A MX9710181 A MX 9710181A
- Authority
- MX
- Mexico
- Prior art keywords
- avidin
- modified
- tyrosine residue
- streptavidin
- type molecules
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/77—Ovalbumin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Peptides Or Proteins (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
Se proveen moléculas del tipo avidina modificadas de union a biotin en donde el residuo de tirosina esencial en el sitio de union a biotin se modifica de tal manera que su pKa disminuye en comparacion con el pKa del residuo de tirosina no modificado en la molécula del tipo avidina no modificada correspondiente; las moléculas del tipo avidina incluyen: (i) avidina de clara de huevo nativa; (ii) avidina recombinante; (iii) formas desglicosiladas de avidina; (iv) estreptoavidina bacteriana; (v) estreptoavidina recombinante; (vi) estreptoavidina truncada; y (vii) derivados de (i)-(vi) que se modifican en sitios diferentes al residuo de tirosina esencial; la modificacion se logra mediante la substitucion en una o ambas posiciones otro al radical hidroxi del residuo de tirosina por radicales tales como nitro, halogeno, azo y amino; las moléculas del tipo avidina modificadas pueden usarse en todas las aplicaciones de la tecnología de avidina-biotin.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11414995A IL114149A0 (en) | 1995-06-14 | 1995-06-14 | Modified avidin and streptavidin molecules and use thereof |
IL114149 | 1995-06-14 | ||
PCT/IL1996/000014 WO1997000329A2 (en) | 1995-06-14 | 1996-06-13 | Modified avidin and streptavidin molecules and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9710181A true MX9710181A (es) | 1998-03-31 |
MXPA97010181A MXPA97010181A (es) | 1998-10-15 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
DE69638257D1 (de) | 2010-10-28 |
HUP9900239A2 (hu) | 1999-05-28 |
ATE481417T1 (de) | 2010-10-15 |
AU6135396A (en) | 1997-01-15 |
WO1997000329A3 (en) | 1997-03-06 |
CN1191018A (zh) | 1998-08-19 |
BR9609241A (pt) | 1999-10-13 |
KR19990022896A (ko) | 1999-03-25 |
HUP9900239A3 (en) | 1999-11-29 |
EP0871658B1 (en) | 2010-09-15 |
JPH11507920A (ja) | 1999-07-13 |
CA2221647A1 (en) | 1997-01-03 |
US5973124A (en) | 1999-10-26 |
EP0871658A4 (en) | 2002-12-04 |
EP0871658A2 (en) | 1998-10-21 |
CN1119353C (zh) | 2003-08-27 |
AU713417B2 (en) | 1999-12-02 |
WO1997000329A2 (en) | 1997-01-03 |
CZ401697A3 (cs) | 1998-07-15 |
IL114149A0 (en) | 1995-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1997000329A3 (en) | Modified avidin and streptavidin molecules and use thereof | |
AU3092997A (en) | Thermosetting, aqueous compositions | |
NZ330897A (en) | Human trk receptors and neurotropic factor inhibitors | |
AU4162400A (en) | Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii | |
TR199902626T2 (xx) | Enflamasyon tedavisi i�in ikameli benzopiran t�revleri. | |
DE69632546D1 (de) | Ob proteinderivate mit verlängerter halbwertzeit | |
ATE177757T1 (de) | Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17 | |
FI925988A0 (fi) | Foerfarande foer framstaellning av b-laktamer | |
IL187595A0 (en) | Antitumor antibodies, proteins, and uses thereof | |
RS50831B (sr) | Izolovano antitelo ili fragment antitela koji se specifično vezuju za rg1 polipeptid | |
ES2185628T3 (es) | Procedimiento para preparar proteinas modificadas. | |
AU3711597A (en) | A novel galanin receptor | |
AU7030700A (en) | Preparation of highly pure toxin fragments | |
FR2723097B1 (fr) | Thioredoxines h de ble tendre et de ble dur et proteines presentant des similitudes, fragments d'adncodant pour ces proteines et procedes d'obtention | |
BG104707A (en) | Caspase-8 interacting proteins | |
AU6700796A (en) | Method for the purification of proteins | |
AU9084682A (en) | Pentapeptide | |
DE69733026D1 (de) | Cyclin e spezifische konstrukte und komplexe | |
GB9723825D0 (en) | Nuclear targeting by means of bacterial proteins | |
DE69627184D1 (de) | 3-aminoethyl-n-amidino-2,5-dihydropyrrol derivative mit arginine-mimetischen eigenschaften | |
AU3569995A (en) | Muramyl peptide compositions for inhibiting hiv replication | |
ES2183543T3 (es) | Derivado de tiocolchicosida, su preparacion y su aplicacion en terapeutica. | |
IT1276454B1 (it) | Metodo per la diagnosi di infezioni helycobacter pylori e relativo corredo diagnostico. | |
WO1994021273A3 (de) | VERWENDUNG VON ANGIOGENIN UND/ODER α1-MICROGLOBULIN UND/ODER KOMPLEMENTFAKTOR D ZUR BEGRENZUNG DER SEKRETION VON PROTEINEN | |
AU2024497A (en) | Cycloalkyl derivatives and the solid-phase synthesis of such derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |